Privia Health Group, Inc. Cash and Restricted Cash
Privia Health Group, Inc. (PRVA) had Cash and Restricted Cash of $412.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $412.20M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $419.52M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $479.69M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $441.35M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $412.20M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $419.52M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $479.69M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $441.35M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $390.13M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $469.33M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $491.15M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $422.00M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $387.35M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $351.14M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $389.51M 10-K · filed 2026-02-27 |
| 2023-09-30 | $330.39M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $317.94M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $311.23M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $347.99M 10-K · filed 2026-02-27 |
| 2022-09-30 | $316.90M 10-Q · filed 2023-11-03 |
| 2022-06-30 | $292.19M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $315.93M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $320.58M 10-K · filed 2025-02-27 |
| 2021-09-30 | $362.11M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $299.75M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $81.94M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $84.63M 10-K · filed 2024-02-27 |
| 2020-09-30 | $88.19M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $62.76M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $49.80M 10-Q · filed 2021-05-28 |
| 2019-12-31 | $46.89M 10-K · filed 2023-03-01 |
| 2018-12-31 | $39.11M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |